Dovilė Sinkevičiūtė

495 citations
16 papers · 354 indexed · h-index 7

Dovilė Sinkevičiūtė

14 papers receiving 351 citations

Peers

Dovilė Sinkevičiūtė
Comparison fields: 5 of 63
  • Rheumatology 201
  • Immunology and Allergy 35
  • Urology 23
  • Anatomy 5
  • Immunology 69
Replace J.L.M. Koevoet with:
J.L.M. Koevoet Netherlands
Francesca Paolella Italy
Helga Joos Germany
Arnavaz Hakimiyan United States
Linyi Cai China
Catharina Müller Austria
T Tsukazaki Japan
Shuiliang Shi United States
Moon‐Moon Majumdar United States
Masaharu Takigawa Japan
Dovilė Sinkevičiūtė relative to J.L.M. Koevoet Netherlands J.L.M. Koevoet's profile →
Citations per field
00.5×11.6×
J.L.M. Koevoet · 1×
Citations per year

Countries citing papers authored by Dovilė Sinkevičiūtė

Since Specialization
Citations

This map shows the geographic impact of Dovilė Sinkevičiūtė's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dovilė Sinkevičiūtė with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dovilė Sinkevičiūtė more than expected).

Fields of papers citing papers by Dovilė Sinkevičiūtė

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dovilė Sinkevičiūtė. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dovilė Sinkevičiūtė. The network helps show where Dovilė Sinkevičiūtė may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dovilė Sinkevičiūtė, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dovilė Sinkevičiūtė Line = papers co-authored together Dovilė Sinkevičiūtė links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 20250
2 20240
3 20231
4 20236
5 20224
6 202235
7 20226
8 202112
9 20212
10 202115
11 202034
12 202024
13 202014
14 20192
15 2017198
16 20161

About Dovilė Sinkevičiūtė

Dovilė Sinkevičiūtė is a scholar working on Rheumatology, Immunology and Allergy and Immunology, having authored 16 papers that have together received 354 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (6 papers), Cell Adhesion Molecules Research (4 papers), Spondyloarthritis Studies and Treatments (4 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Protease and Inhibitor Mechanisms (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Rheumatology (201 citations), Immunology and Allergy (35 citations) and Urology (23 citations). Dovilė Sinkevičiūtė has collaborated with scholars based in Denmark, Sweden and United Kingdom. Frequent co-authors include Anne‐Christine Bay‐Jensen, Patrik Önnerfjord, M.A. Karsdal, Yi He, Yunyun Luo, Ali Mobasheri, Yves Henrotin, Anders Aspberg, Signe Holm Nielsen and Christian S. Thudium. Their work appears in journals such as Scientific Reports, Osteoarthritis and Cartilage, Cancers, Protein & Cell and Clinical and Experimental Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026